CY1123322T1 - Φαρμακευτικη συνθεση περιλαμβανουσα μπισοπρολολη και περινδροπριλη - Google Patents

Φαρμακευτικη συνθεση περιλαμβανουσα μπισοπρολολη και περινδροπριλη

Info

Publication number
CY1123322T1
CY1123322T1 CY20201100839T CY201100839T CY1123322T1 CY 1123322 T1 CY1123322 T1 CY 1123322T1 CY 20201100839 T CY20201100839 T CY 20201100839T CY 201100839 T CY201100839 T CY 201100839T CY 1123322 T1 CY1123322 T1 CY 1123322T1
Authority
CY
Cyprus
Prior art keywords
bisoprolol
pharmaceutical composition
perindropril
composition including
composition
Prior art date
Application number
CY20201100839T
Other languages
English (en)
Inventor
Gilles Fonknechten
Original Assignee
Les Laboratoires Servier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52345359&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1123322(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Les Laboratoires Servier filed Critical Les Laboratoires Servier
Publication of CY1123322T1 publication Critical patent/CY1123322T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Σταθερή φαρμακευτική σύνθεση περιλαμβάνουσα βήτα-αναστολέα, μπισοπρολόλη και αναστολέα ενζύμου μετατροπής αγγειοτασίνης, περινδοπρίλη και χρήση της εν λόγω σύνθεσης για θεραπεία ή αποτροπή καρδιαγγειακών ασθενειών και πιο ιδιαιτέρως, αρτηριακής υπέρτασης, σταθερής νόσου στεφανιαίας αρτηρίας ή χρόνιας καρδιακής ανεπάρκειας.
CY20201100839T 2014-11-05 2020-09-07 Φαρμακευτικη συνθεση περιλαμβανουσα μπισοπρολολη και περινδροπριλη CY1123322T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1460654A FR3027803B1 (fr) 2014-11-05 2014-11-05 Composition pharmaceutique comprenant un betabloquant et un inhibiteur de l'enzyme de conversion
PCT/FR2015/052975 WO2016071631A1 (fr) 2014-11-05 2015-11-04 Composition pharmaceutique comprenant le bisoprolol et le périndopril

Publications (1)

Publication Number Publication Date
CY1123322T1 true CY1123322T1 (el) 2021-12-31

Family

ID=52345359

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20201100839T CY1123322T1 (el) 2014-11-05 2020-09-07 Φαρμακευτικη συνθεση περιλαμβανουσα μπισοπρολολη και περινδροπριλη

Country Status (24)

Country Link
EP (1) EP3215130B1 (el)
CY (1) CY1123322T1 (el)
DK (1) DK3215130T3 (el)
EA (1) EA032808B1 (el)
ES (1) ES2811904T3 (el)
FR (1) FR3027803B1 (el)
GE (1) GEP20196989B (el)
HR (1) HRP20201518T1 (el)
HU (1) HUE051947T2 (el)
LT (1) LT3215130T (el)
MA (1) MA40915B1 (el)
MX (1) MX2017005848A (el)
MY (1) MY187357A (el)
PH (1) PH12017500786B1 (el)
PL (1) PL3215130T3 (el)
PT (1) PT3215130T (el)
RS (1) RS60657B1 (el)
RU (1) RU2702362C2 (el)
SG (2) SG10201903656RA (el)
SI (1) SI3215130T1 (el)
TN (1) TN2017000170A1 (el)
UA (1) UA122131C2 (el)
WO (1) WO2016071631A1 (el)
ZA (1) ZA201703078B (el)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR127403A1 (es) 2021-10-20 2024-01-17 Servier Lab Nuevas sales de trimetazidina

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003092729A1 (de) 2002-05-03 2003-11-13 Hexal Ag Stabile pharmazeutische formulierung für eine kombination aus einem statin mit einem ace-hemmer
WO2007010501A2 (en) * 2005-07-22 2007-01-25 Ranbaxy Laboratories Limited A pharmaceutical composition comprising a combination of beta blocker and an ace inhibitor
HU230877B1 (hu) * 2008-09-30 2018-11-29 EGIS Gyógyszergyár NyR Stabil kombinációs gyógyszerkészítmény
AU2010242938A1 (en) * 2009-04-30 2011-11-17 Dr. Reddy's Laboratories Ltd. Fixed dose drug combination formulations
HUE029647T2 (en) 2010-05-06 2017-03-28 Cal Int Ltd Pharmaceutical composition containing aspirin and bisoprolol

Also Published As

Publication number Publication date
HRP20201518T1 (hr) 2020-12-11
PL3215130T3 (pl) 2020-11-16
HUE051947T2 (hu) 2021-03-29
RU2017115341A (ru) 2018-11-05
EA032808B1 (ru) 2019-07-31
LT3215130T (lt) 2020-08-25
UA122131C2 (uk) 2020-09-25
MX2017005848A (es) 2017-06-27
RS60657B1 (sr) 2020-09-30
SI3215130T1 (sl) 2020-11-30
FR3027803A1 (fr) 2016-05-06
WO2016071631A1 (fr) 2016-05-12
PT3215130T (pt) 2020-08-26
ES2811904T3 (es) 2021-03-15
DK3215130T3 (da) 2020-09-21
EA201790772A1 (ru) 2017-09-29
EP3215130A1 (fr) 2017-09-13
SG10201903656RA (en) 2019-05-30
TN2017000170A1 (fr) 2018-10-19
SG11201703550SA (en) 2017-06-29
EP3215130B1 (fr) 2020-07-08
PH12017500786A1 (en) 2017-10-02
MA40915B1 (fr) 2020-08-31
FR3027803B1 (fr) 2018-02-09
MY187357A (en) 2021-09-22
GEP20196989B (en) 2019-07-10
PH12017500786B1 (en) 2017-10-02
RU2017115341A3 (el) 2019-05-21
RU2702362C2 (ru) 2019-10-08
ZA201703078B (en) 2020-11-25

Similar Documents

Publication Publication Date Title
CY1120903T1 (el) Ενωσεις αμινοπυριδυλοξυπυραζολιου
CY1124959T1 (el) Αναστολεις λυσινης ειδικης απομεθυλασης-1
CY1123810T1 (el) Τριφθορομεθυλ υποκατεστημενα πυραζολια ως αναστολεις καλλικρεϊνης στο ανθρωπινο πλασμα
CY1124407T1 (el) Ενωσεις αναστολεα αυτοταξινης
CY1123391T1 (el) (2s)-n-[(1s)-1-kyano-2-φainyλaιθyλ]-1,4-oξazeπan-2-καρβοξαμιδια ως αναστολεις της διπεπτιδυλικης πεπτιδασης ι
CY1124548T1 (el) Παραγωγα μονο- ή δισυποκατεστημενης ινδολης ως αναστολεις αναδιπλασιασμου του δαγκειου ιου
CY1123475T1 (el) Αναστολεις της ειδικης για λυσινη απομεθυλασης-1
MX2022007989A (es) Composiciones y metodos para tratar pterigion.
EA201790765A1 (ru) Производные спиродиамина в качестве ингибиторов альдостерон-синтазы
EA201692436A1 (ru) Медицинское применение
CY1126036T1 (el) Δοσολογικο σχημα σακουμπιτριλης-βαλσαρτανης για τη θεραπευτικη αντιμετωπιση της καρδιακης ανεπαρκειας
EA201692091A1 (ru) Хиноксалиновые соединения и их применение
CY1123477T1 (el) Παραγωγα βενζοξαζινονης για την αγωγη δερματικων νοσων
BR112019003533A2 (pt) terapia de combinação com inibidores de glutaminase
CY1124907T1 (el) Αναστολεις καλλικρεϊνης στο ανθρωπινο πλασμα
CY1121345T1 (el) Φαρμακευτικες συνθεσεις και χρησεις που απευθυνονται σε διαταραχες λυσοσωμιακης αποθηκευσης
EA201790046A1 (ru) Бензоксазиноновые амиды в качестве модуляторов минералокортикоидного рецептора
JP1638163S (ja) 内視鏡用プロセッサ
EA201990095A1 (ru) КОНДЕНСИРОВАННЫЕ ТИОФЕНОВЫЕ ПРОИЗВОДНЫЕ, ПРИЕМЛЕМЫЕ В КАЧЕСТВЕ ИНГИБИТОРОВ NAPI-IIb
CY1126054T1 (el) Πεπτιδια για θεραπεια και αποτροπη διαβητη και συναφων διαταραχων
CY1123322T1 (el) Φαρμακευτικη συνθεση περιλαμβανουσα μπισοπρολολη και περινδροπριλη
NI201600091A (es) UREAS ASIMÉTRICAS p-SUSTITUIDAS Y USOS MÉDICOS DE LAS MISMAS
EA201692471A1 (ru) Антиретровирусное лекарственное средство, нацеленное на эндогенный ретровирус человека
EA201700254A1 (ru) Комбинация
BR112017005993A2 (pt) derivados de peptídeo inovadores e usos dos mesmos